Remote monitoring of myasthenia gravis using MyoSense 360 app
Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.
This trial uses a smartphone app and an activity tracker to remotely monitor symptoms of generalized myasthenia gravis (gMG). It aims to improve how doctors track your condition from home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with generalized myasthenia gravis (gMG) by a doctor.
- You own a personal smartphone with iOS 16 or newer, or Android 8 or newer.
- You are able to read one of the languages available in the MyoSense 360 app.
- You are willing and able to wear an activity monitor (like a Fitbit) during the study.
- If you live in France, you must be covered by social security and not have received more than €6,000 in clinical trial payments in the past year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses wearable sensors and smartphone apps to track your myasthenia gravis symptoms over time. It aims to see how well these technologies can measure your condition in daily life, which could help you and your doctor manage your care better.
This study uses a smartphone app (BioDigit MG) to monitor how your myasthenia gravis symptoms change after you start treatment with VYVGART or VYVGART Hytrulo. It aims to see if the app can reliably measure disease activity.
This study uses lab-grown mini muscle-nerve cells (organoids) to better understand severe, hard-to-treat myasthenia gravis. It may help researchers find new treatment options for people with the AChR antibody type.
This study tests whether remote monitoring through smartphone apps can effectively track myasthenia gravis symptoms and help manage care from home, instead of frequent in-person visits.
This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.
This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.
Hear when a new Myasthenia Gravis, Generalized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.